Bassia longifolia Koen.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | Madhuca longifolia (Linn.) Macbride. |
| Family | Sapotaceae. |
| Habitat | South India; common in the monsoon forests of Western Ghats. |
| English | Mowra Butter tree, South Indian Mahua. |
| Siddha / Tamil | Illupei, Elupa, Naatu, Iluppei, Iruppei. |
| Action | Flowers—laxative, bechic (used in coughs, colds and bronchitis), stimulant and nervine tonic. Seed oil—galactogenic, anticephalalgic, laxative in cases of habitual constipation and piles; used externally in rheumatism and skin affections. Bark, seed oil and gum—antirheumatic. |
| Taxonomic Cohort | Genus Bassia (1 documented species); Family Sapotaceae (7 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Bassia longifolia (taxonomically cited with authority Koen.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Sapotaceae (primary family classification: Sapotaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy Madhuca longifolia (Linn.) Macbride, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: South India; common in the monsoon forests of Western Ghats.
Across classical and vernacular Indian systems of medicine, Bassia longifolia is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Mowra Butter tree, South Indian Mahua; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Illupei, Elupa, Naatu, Iluppei, Iruppei. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bassia longifolia are: Flowers—laxative, bechic (used in coughs, colds and bronchitis), stimulant and nervine tonic. Seed oil—galactogenic, anticephalalgic, laxative in cases of habitual constipation and piles; used externally in rheumatism and skin affections. Bark, seed oil and gum—antirheumatic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Bassia longifolia establish the following evidence base: The herb contains 17% tannins and is used for bleeding and spongy gums, tonsillitis, ulcers, rheumatism and diabetes mellitus. Roots are applied to ulcers. Seed kernel gave protobassic acid (a sapogenol) and two major saponins— Mi-saponins A and B. Mi-saponins (bisdesmosides of protobassic acid) exhibit anti-inflammatory activity in rheumatism. The carollas are a rich source of sugars and contain an appreciable amount of vitamins and calcium (total sugars 72.9%, calcium 140 mg/100 g). Sugars are identified as sucrose, maltose, glucose, fructose, arabinose and rhamnose. Flowers are largely used in the preparation of distilled liquors. They constitute the most important raw material for fermentative production of alcohol.

Botanical Reference 1: Bassia longifolia — Wikimedia Commons

Botanical Reference 2: Bassia longifolia — Wikimedia Commons

Botanical Reference 3: Bassia longifolia — Wikimedia Commons
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Bassia longifolia stands as a distinct representative of the genus Bassia. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Sapotaceae encompasses 7 documented medicinal species (0.39% of the 1,814-species flora). Other representative medicinal members of Sapotaceae include: Achras zapota (Sapota), Madhuca butyracea (Madhuuka), Madhuca indica (Madhuuka), Madhuca longifolia (South Indian Mahua), Manilkara kauki (Khirni). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 7 medicinal species of family Sapotaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Bassia longifolia follow the plant-part modalities specified under its therapeutic action (Flowers—laxative, bechic (used in coughs, colds and bronchitis), stimulant and nervine tonic. Seed oil—galactogenic, anticephalalgic, laxative in cases of habitual constipation and piles; used externally in rheumatism and skin affections. Bark, seed oil and gum—antirheumatic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Bassia longifolia integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.